To cite this paper use one of the standards below:
Cannabicitran [(±)-CBT-C, 1] is a minor phytocannabinoid found in very low concentrations (0.2-0.9%) in the flowers of female Cannabis sativa plants1 and has been the subject of a limited number of pharmacological studies.2 (±)-CBT-C (1) is biosynthesized from the phytocannabinoid cannabigerol (CBG, 3), via
cannabichromene [(±)-CBC, 2], and has been synthesized using inefficient approaches.3 Herein, we accomplished the bioinspired synthesis of (±)-CBT-C (1) and its derivatives (4 and 5) via a DDQ-promoted double cyclization of CBG (3) and corresponding derivatives,4 in yields ranging from 18% to 62%. The double cyclization is presumed to involve a hydride abstraction5 followed by an oxidation-reduction sequence, both mediated by DDQ, which can be affected by strongly electron-withdrawing substituents. Consequently, (±)-CBC derivatives (6 and 7) were obtained in some cases, with yields of 55% and 56%. Currently, efforts toward the reoptimization of the reaction conditions for compounds 4 and 5 are underway.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper